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Abstract 
 
Purpose of Review 
To examine the most recent literature that provides new data regarding the potential and emerging 
biomarkers for zinc status in individuals. 
Recent findings 
Suboptimal dietary zinc intake is estimated to affect 17% of the world’s population, however the 
assessment of zinc status is notoriously difficult.  A systematic review and meta-analysis of studies 
investigating biochemical biomarkers of zinc status was conducted by the European Micronutrient 
Recommendations Aligned (EURRECA) network. This review summarised the data published from 
inception to 2007. More recently (2016), an international expert panel, convened by the Biomarker 
of Nutrition for Development (BOND) initiative, published an extensive review the literature 
addressing biomarkers of zinc status in populations and individuals and categorised the biomarkers 
as useful (dietary intake, serum [Zn], stunting), potentially useful (hair [Zn], urine [Zn], 
neurobehavioural function), and emerging (nail [Zn], oxidative stress and DNA integrity, zinc kinetics, 
zinc dependent proteins, taste acuity).   
Summary 
The most recent data on the potentially useful biomarkers support the further investigation of hair 
[Zn] and indices of neurological function, particularly those assessing memory and attention. Of the 
emerging biomarkers, the measurement of DNA integrity and the expression of zinc transport 
proteins look promising.  
 
Key words: Zinc, biomarker, status  
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Introduction 
Inadequate dietary zinc intake affects 17% of the world’s population, and the assessment of zinc 
status in individuals and populations is key to informing our understanding of zinc homeostasis in 
health and disease, and to evaluating the efficacy of zinc supplementation programmes. In 2009, a 
comprehensive systematic review and meta-analysis of zinc biomarkers from inception to 2009 was 
published by the  EURRECA consortium (1) in which 32 potential biomarkers were considered.   The 
meta-analysis revealed that, plasma or serum Zn concentration ([Zn]), hair and urine [Zn] did 
respond to changes in dietary zinc intake and were useful biomarkers of zinc status, with specific 
caveats. However, for many biomarkers, there were insufficient data to fully evaluate their potential. 
More recently complete review of zinc biomarkers was published in a report by the Biomarkers of 
Nutrition for Development (BOND), zinc expert panel (2).  This review considered both biochemical 
and functional indicators of zinc status, and classified them into four categories; “recommended”, 
“potential”, “emerging” and “not useful”. A potential biomarker is one that shows promise but data 
are in-sufficient to establish a specific cut-off indicating zinc inadequacy in populations.  These 
include hair and urinary [Zn], and neuro-behavioural function.  Emerging biomarkers are those for 
which there is some theoretical basis of a relationship to zinc intake or status, but the testing is 
insufficient to confirm the relationship.  These include nail [Zn], zinc-dependent proteins, oxidative 
stress and DNA integrity, zinc kinetics and taste acuity (table 1). 
The purpose of this review is to examine the recently published data regarding the potential and 
emerging biomarkers for individuals identified by BOND. 
Insert Table 1 here.  
Review 
 MEDLINE and EMBASE databases were searched from January 1st 2015 to April 1st 2016 for 
publications investigating each of the potential and emerging biomarkers listed in table 1. The search 
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was limited to English language and human studies, full papers.  Abstracts and reviews were 
excluded unless the review included a meta-analysis (3). The papers identified for inclusion in this 
review are summarised in Table 2.  
Insert table 2 here.  
Hair [Zn]  
Zinc is a structural component of the hair matrix, formed in the follicle. Hair [Zn] therefore reflects 
the availability of zinc from the blood supply at the time of formation (2). Hair has the advantage of 
being easily collected and is stable indefinitely if stored appropriately.  Included studies collected 
hair samples ranging from 0.2 to 2g, from the nape of the neck, adjacent to scalp (4, 6), or from 1.5 
cm from scalp at the nape or occipital region (5). Hair samples were washed in deionised water, 
dried and acid digested prior to analysis by either atomic absorption spectrometry (AAS) (4, 5) or 
inductively couple plasma mass spectrometry (ICPMS) (6).  
Children  
Gao et al. evaluated the relationship between hair [Zn], growth and indices of cognitive 
development in young children from 13 provinces in China.  Anthropometric measures were 
assessed alongside hair [Zn].    The tenth percentile (P10) of hair [Zn] of children in each age group 
served as the threshold value, with a value below P10 indicating hair zinc deficiency.  The P10 values 
for children aged 3-4 years was 47.5 µg/g, and 41.3 µg/g for children aged 4-5 years. Overall 15.46% 
of children had hair zinc deficiency.   There were no significant correlations between hair [Zn] and 
anthropometry, except for weight for age in boys (p=0.04) but not girls. When separated into 2 
groups (below and above threshold P10 value), there were no significant differences in 
anthropometric measures.  
A study undertaken in school children in Cuba by de Gier et al (5),  examined hair [Zn] as a marker of 
zinc status alongside anthropometric measures, in children with and without soil transmitted 
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helminth infections (STH) (5).  The median (IQR) hair [Zn]s for the STH infected and uninfected 
children were 113.35 µg/g (94.4-143.7) and 112.55 µg/g (88.3-136.0) respectively.  Overall, 12.2 % of 
the children were deemed to be zinc deficient based on a cut-off value < 70 µg/g ((16). The overall 
association between hair [Zn] and height for age was not significant but did show a positive trend 
(p=0.082).  When stratified for helminth infection, the uninfected children had a significant positive 
association (p=0.033) between hair [Zn] and height for age, but there was no association in infected 
children.   
Adults 
Koc et al (6)  compared hair and serum [Zn] in patients with Alzheimer disease.   Hair [Zn] was 
significantly lower (p=0.02) in patients (75 µg/g ±29) vs control (98 µg/g ±54), however there were 
no significant differences in serum [Zn] between the Alzheimer patients (0.47 ± 0.1 µg/ml) and 
healthy controls (0.52 ±0.3 µg/ml).  
A systematic review and meta-analysis was performed by Bin Liu et al., examining the relationship 
between [Zn] in hair, serum (or plasma), and myocardial infarction (MI). The meta-analysis of pooled 
data revealed that both serum [Zn], and hair [Zn] were significantly lower in patients with MI. The 
lower serum [Zn] in MI patients may be due to the acute phase response, however the authors 
contend that hair [Zn] represents a longer term measure of the zinc status of the patient, and may 
indicate an underlying chronic zinc deficiency in MI patients that could be a causal factor in the 
condition.  
The studies in children enabled a comparison between hair [Zn] and growth.  However only one of 
the studies reported a significant association between hair [Zn] and height for age (5).  The studies in 
adults enabled an evaluation of hair zinc alongside serum [Zn].  Both studies reported a fall in hair 
[Zn] in the patient groups, one without a concurrent fall in serum [Zn], suggesting a possible 
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advantage in measuring hair over [Zn] for chronic zinc deficiency, and in the presence of the acute 
phase response.  
Neurobehavioral and cognitive function 
Zinc plays a key role in neurodevelopment from conception through childhood.  In addition, it acts a 
neurotransmitter, playing a role in learning and memory function throughout life.   Five studies were 
identified that measured indices of zinc status and neurobehavioral and cognitive function, one was 
conducted in infants (7), two in pre-school aged children (4, 8) and two in older adults (9, 10).  
Infants and children 
In order to assess the relationship between zinc status and brain development in infants adopted 
internationally into families in the USA Fuglestad et al (7) conducted a comprehensive nutritional 
and neurodevelopmental assessment at baseline (within one month of arrival) and a six month 
follow-up. Infants (n=53) raised by biological parents in the USA served as controls to establish the 
normative data for neurodevelopment.   Neurodevelopment assessment included general cognitive 
and motor development (Bayley Scales of Infant Development-III, BSID-III). In addition, at follow-up, 
memory function was tested using elicited imitation tests. At baseline, anthropometric measures 
revealed that 35% of the adopted children were stunted (HAZ<2) and 29% were zinc deficient 
(serum [Zn] < 60 µg/dl)]. Changes in the rates of deficiencies from baseline to follow-up were not 
statistically significant, with the exception of a reduction in stunting. Neurological function tests 
revealed that adoptees with zinc deficiency had significantly poorer performance in the elicited 
imitation test than those with normal zinc status and those with iron deficiency had lower BSID-III 
scores than controls. There were no differences in any of the neurodevelopmental measures 
between the deficient and sufficient groups for vitamin D, vitamin A or iodine/selenium.  
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Gao et al (4) examined scores of intelligence quotient (IQ) and adaptation development quotient 
(ADQ)alongside hair [Zn] and anthropometric measures in young Chinese children. They reported a 
positive correlation between hair [Zn] and ADQ in boys, but not IQ in either boys or girls.  
Warthon-Medina et al (8) performed a follow-up study in pre-school children (n=200) living in an 
economically deprived area in Lima, Peru who received multiple either micronutrient supplements 
(containing zinc) or Iron alone during infancy.  Indices of motor development, IQ, working memory 
and executive function were measured. No long term impact of multiple micronutrient 
supplementation compared with iron alone were identified.  
Older adults 
Alghadier et al (9) used the Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) 
battery.  Serum [Zn], the serum concentration of iron ([Fe]) and copper ([Cu]) were measured. 
Participants were grouped according to their overall LOTCA score, normal, moderate decline and 
severe decline.  Analysis of the data revealed a significantly lower serum [Zn] and higher [Fe] and 
[Cu] in participants with severe and moderately impaired cognitive performance ([Zn]: 48.9±3.4 and 
65.4±1.6 µg/dL respectively) compared to normal ([Zn]: 78.3±2.5 µg/dL), p=0.01.  Higher serum [Fe] 
and [Cu], and lower [Zn] were strongly associated with poorer cognitive performance, specifically in 
tests of long-term memory, motor praxis, vasomotor organisation, thinking operations, attention 
and concentration.  
Markeiwicz-Zukowska (10) measured cognitive impairment using the Abbreviated Mental Test Score 
(AMTS) which is used to screen for signs of dementia,  and emotional status was examined using the 
Geriatric Depression Scale (GDS).   Serum [Zn] was higher (p=0.001) in subjects with unimpaired 
cognitive function (89 ± 20 µg/dL) compared to those with memory impairment (76 ± 22µg/dL).  
Serum [Zn] was positively correlated with AMTS (p<0.001) and negatively correlated with GDS 
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(p=0.006). Those with signs of depression had significantly lower werum [Zn] (77±17 µg/dL) 
compared to those without depression (89±22 µg/dL).   
Taken together, these studies provide supportive evidence for the use of some aspects of cognitive 
function particularly those associated with memory, as functional markers of zinc status.   
Zinc dependent proteins 
The gene expression of the zinc binding protein, metallothionein (MT), and the zinc transporters 
(ZnT and ZIP families) were highlighted in the BOND review as emerging biomarkers of zinc status. 
These proteins are involved in the regulation of cellular zinc homeostasis, and thus have been 
postulated to respond to changes in dietary zinc intake.    The search yielded 3 relevant studies 
investigating MT and/or zinc transporters (11, 13, 17). 
Metallothionein and zinc transport proteins 
A randomised control trial to examine the impact of zinc supplementation on the gene expression of 
MT and the zinc transporters was undertaken by Chu et al (11). Healthy adults were randomised to 
receive 22 mg elemental zinc per day for 21 days or no treatment.  Blood was collected at intervals 
for 3 weeks and the ZIP, ZnT and MT mRNA was extracted and quantified from peripheral blood 
mononuclear cells (PBMC). Plasma [Zn] was also measured and dietary intake estimated from 3-day 
food records.  Zinc supplementation did not change the gene expression of the zinc transporters or 
MT1A.   Expression of MT2-A  was higher in the zinc supplemented group compared to controls 
(p=0.025), and this transient upregulation occurred within 2 days of zinc supplementation but 
returned to values close to  that of the control group by day 7.  Plasma [Zn] was not significantly 
altered by supplementation.  Multivariate analysis revealed that baseline dietary zinc intake was a 
significant predictor of all measured ZIP, ZnT and MT gene expressions, explaining 61% of the 
variance in gene expression.  MT1-A and ZIP10 expression were both significant univariate factors 
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(p=0.002 and 0.045 respectively). Plasma [Zn] was not correlated with the gene expression of any of 
the proteins, nor did the change in gene expression following supplementation predict plasma [Zn].  
In the study conducted by Sharif et al (12), elderly participants with low plasma [Zn] (<77 µg/dL), 
were randomly allocated to receive either a zinc supplement of 20 mg per day or a placebo for 12 
weeks.  RNA was isolated from lymphocytes and the expression of MT1-A and ZIP1 was measured 
along with plasma [Zn] at baseline and endpoint. Both MT1A and ZIP1 expression increased 
significantly in the zinc supplemented group compared to placebo (p<0.05). Plasma [Zn] also 
increased significantly in the supplemented group, and correlated with ZIP1 expression (r=0.576, 
p=0.039) post supplementation. 
Giacconi et al (13) also studied the response to zinc supplementation in elderly participants with low 
plasma [Zn]s (<68.6 µg/dL). The study was designed to investigate a single nucleotide polymorphism 
(SNP) on the encoding region of the ZIP2 gene.  Participants were grouped according their genotype 
(Leu+ or Leu-) and all were given a 10 mg/day supplement of zinc for 48±2 days. The expression of 
ZIP and ZnT proteins was measured in PBMCs, pre and post supplementation. There were some 
significant differences in the expression of zinc transport proteins at baseline between the two 
genotypes. In terms of changes in gene expression post supplementation, both genotypes exhibited 
a significant decrease in ZIP2 and ZIP3 mRNA, no significant changes in expression of the other 
transporters were reported. PBMC MT levels increased significantly post supplementation in all 
participants, with no differences according to genotype. 
These studies contribute some valuable data to this emerging area of research. In the absence of 
pre-existing zinc deficiency there appears to be no change in the expression of the zinc transporters 
following supplementation  (11), however, the level of transport gene expression may reflect the 
longer term dietary zinc intake levels.  If zinc deficiency is present, there does appear to be an 
increase in ZIP1 and a decrease in ZIP2 and ZIP3 gene expression in response to supplementation, 
however it should be noted that baseline gene expression may vary depending on the presence of 
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SNPs. Total MT in PBMC and MT-2A gene expression increased following zinc supplementation, 
irrespective of baseline zinc status. 
Oxidative Stress and DNA integrity 
Zinc is a cofactor or structural component for proteins involved in DNA damage repair. Zinc 
deficiency therefore has deleterious effect on DNA integrity, resulting in an increase in the number 
of strand breaks. Two studies were identified that evaluate the impact of zinc supplementation on 
DNA damage in participants with low zinc status, both used the comet assay (12, 14) .  
Joray et al (14) studied a group of Ethiopian women with low dietary zinc and high phytate intakes. 
Average baseline plasma [Zn] was 73.4 ±2.0 µg/dL and 37% of the women had values below the cut-
off of 70.0 µg/dL. They received 20 mg zinc or placebo daily for 17 days.    Blood taken at baseline 
and endpoint. Zinc supplementation did not significantly affect plasma [Zn], however the mean 
comet tail moment decreased significantly (p<0.005) post supplementation and there was a 
significant negative correlation between plasma [Zn] and tail moment at the endpoint (r=-0.42, 
P=0.02) but not at baseline.   
In the study of elderly zinc deficient participants by Sharif et al (12) described previously, DNA 
damage was measured using the comet assay and also the cytokinesis-block micronucleus cytome 
(CBMN-Cyt) assay.  Data from the comet assay revealed significant effect of time and treatment of 
zinc supplementation for both tail moment and tail intensity (p<0.05) which both decreased relative 
to baseline (7.53% and 8.76% respectively).  Plasma zinc was inversely correlated with tail moment 
after 12 weeks of supplementation (r=-0.219, p=0.045). The CBMN-Cyt assay also revealed a 
significant reduction in DNA damage post supplementation relative to baseline.  
These studies both provide further evidence that, in zinc deficient individuals, there is a measurable 
reduction DNA damage following zinc supplementation. This occured irrespective of a concurrent 
increase in plasma [Zn]. Further studies are needed to confirm this observation in different settings 
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and populations (infants, children, pregnancy), and the impact of other nutrient deficiencies that 
may affect the assay.  
Taste acuity 
Zinc is a component of gustin, a protein involved in taste perception, thus it has been postulated 
that zinc deficiency impairs taste acuity.  Kim et al (15) studied haemodialysis patients, divided into 2 
groups depending on their serum [Zn]; a zinc deficient group, (serum zinc <70 µg/dL) and zinc 
sufficient (serum zinc >70 µg/dL). Salt taste acuity and preference were determined by a sensory test 
using varying concentrations of NaCl solution. The mean threshold salt concentration for perception 
was significantly higher in the zinc deficient group (p=0.02), supporting an inverse relationship 
between zinc status and taste acuity.   
Conclusion 
New data, published since January 2015,  provide a valuable contribution to the evaluation of the 
potential and emerging biomarkers of zinc status in individuals, identified by the BOND expert zinc 
panel (2).  In the absence of a “gold standard”, potential biomarkers can only be compared against 
what is routinely used, and for which there is already a significant body of evidence, namely plasma 
(or serum) [Zn], growth and dietary zinc intake.  Never-the-less, there are some exciting new 
possibilities that warrant further investigation.  
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Key points 
1. The assessment of zinc status in individuals is notoriously difficult, however recent 
comprehensive reviews have identified useful, potential and emerging biomarkers of zinc 
status 
2. Newly published data support the use of hair [Zn] and indices of neurological function 
including memory and attention.  
3. There is further evidence supporting the measurement of DNA integrity (using the comet 
assay).  
4. Changes in the gene expression of zinc transport proteins in response to supplementation 
warrant further investigation.  
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Table 1.  Summary of Biomarkers of Zinc status according the categories identified by the BOND Zn 
expert panel (summarised from King et al (2))  
Recommended Potential Emerging Not Useful 
Dietary 
assessment  
Hair Zinc Nail Zinc Zinc dependent 
enzymes 
Plasma or serum 
zinc 
concentration 
Urinary Zinc Zinc-dependent 
proteins 
Erythrocyte and 
leukocyte zinc 
Stunting Neurobehavioral 
function  
Oxidative stress 
and DNA 
integrity 
 
  Zinc kinetics  
  Taste acuity  
 
 
Table 1
Table 2.  Summary of the publications included in this review. 
Potential 
Biomarker 
Reference  Relevant outcome measures Population Evidence supports 
potential * 
Hair [Zn] Gao et al (4)  
 
 
Hair [Zn]  plasma [Zn], anthropometry 
(height, weight and head circumference),  
Intelligence Quotient, Adaptation 
Development Quotient 
Chinese school children aged 3-5 
years, n=8102 
0 
de Gier et al (5) 
 
Hair [Zn], height for age Z score Cuban children aged 4 to 17 years 
with (n=60) and without (n=120) 
helminth infection 
+ 
Koc et al (6) 
 
Hair [Zn], serum [Zn] Turkish adults with Alzheimer 
disease (n=22 women, n=23 men) 
and healthy adults (n=17 women, 
n=16 men) 
+ 
Bin Liu et al (3) Hair [Zn], serum or plasma [Zn] Meta-analysis of studies of adults 
with and without Myocardial 
Infarction  
+ 
Neurobehavioural 
and cognitive 
function 
Fuglestad et al (7) Neurological development (Bayley Scales 
of Infant Development-III, elicited imitation 
tests), anthropometry (height and weight, 
weight for height z scores), serum [Zn], 
retinol binding protein, biochemical  
indices of iron, iodine, vitamin  B12, 
selenium, vitamin D, vitamin A status 
Infants aged 8-18 months, n=53, 
adopted into the USA from post-
Soviet States (n=15), Ethiopia 
(n=26) and China (n=17). 
++ 
Gao et al (4) 
 
 
 
 
Intelligence Quotient (Bitnet and Raven 
intelligence scales), Adaptation 
Development Quotient (behavioural 
adaptation scale), hair [Zn],  plasma [Zn], 
anthropometry (height, weight and head 
circumference). 
 
Chinese school children aged 3-5 
years, n=8102 
 
 
+ 
Table 2
Warthon-Medina et al 
(8) 
 
Cognitive and executive function (Wechsler 
Preschool and Primary Scale of Intelligence 
(WPPSI) Verbal IQ sentences subtest, the 
Day-Night  Stroop test, nine boxes memory 
test, theory of mind test, Brief Infant-
Toddler Social Emotional Assessment 
(BITSEA)) 
Peruvian pre-school children, aged 
3-4 years, n=200, follow up study 
to previous supplementation with 
multiple  micronutrients (zinc,iron, 
folic acid, vitamins C and A) or Iron 
alone for 6 months during infancy 
(aged 6-19 months) 
0 
Alghadir et al (9) 
 
Cognitive performance (Loewenstein 
Occupational Therapy Cognitive 
Assessment battery, including orientation, 
visual perception, spatial perception, 
motor praxis, vasomotor organisation, 
thinking operations, attention and 
concentration), serum [Zn] 
Healthy older adults aged 64-96 
years, (n=100) 
 
++ 
Markeiwicz-Zukowska et 
al  (10) 
 
Cognitive and executive function 
(Abbreviated Mental Test Score, Geriatric 
Depression Scale) 
Older adults aged 60-102 years, 
n=130 
 
++ 
Emerging 
Biomarkers 
    
Zinc-dependent 
proteins 
Chu et al (11) MT mRNA MT (MT-1A, MT-2A), ZnT mRNA 
(ZnT 1, ZnT5, ZnT6, ZnT7), and ZIP mRNA, 
(ZIP1, ZIP3, ZIP7, ZIP8, ZIP10, ZIP14), 
plasma [Zn], serum CRP, dietary Zn intake 
Healthy Adults aged 18-65 years, 
randomised to receive 22 mg 
elemental zinc per day for 21 days 
(n=20) or no treatment (n=19) 
++ 
Sharif et al (12) ZnT mRNA ZIP mRNA, DNA integrity, 
dietary Zn intake, plasma [Zn] 
Healthy Australian elderly adults 
aged 65-85 years, with low plasma 
[Zn] randomised to receive 22 mg 
elemental zinc per day for 21 days 
(n=20) or no treatment (n=19)   
++  
Giacconi et al (13) ZnT mRNA (ZnT1, ZnT6), , ZIP mRNA (ZIP 1, 
ZIP2, ZIP3, ZIP8), MT, Plasma [Zn] 
 
 
 
 European elderly adults with low 
plasma [Zn], aged 74.6 ± 68.7 years 
(n=1090), classified based on ZIP2 
SNP Leu- (n=535) or Leu+ (n=555). 
++ 
All received Zn supplements, 10 mg 
per day for 48±2 days 
Oxidative stress 
and DNA integrity 
Joray et al (14) DNA integrity (comet assay), plasma [Zn] Zinc deficient Ethiopian women, 
n=40. Randomly assigned to 
receive 20 mg zinc (n=20) or 
placebo (n=20) daily for 17 days 
++ 
Sharif et al (12) DNA integrity (comet assay), plasma [Zn], 
ZnT mRNA ZIP mRNA, dietary Zn intake 
Healthy Australian elderly adults 
aged 65-85 years, with low plasma 
[Zn] randomised to receive 22 mg 
elemental zinc per day for 21 days 
(n=20) or no treatment (n=19)   
++ 
Taste Acuity Kim et al (15) Salt Taste acuity, serum [Zn], dietary 
assessment (3-day diet diary) 
Adult end stage kidney disease 
patients receiving haemodialysis 
(n=77).  
++ 
 
 
* 0 no evidence supporting biomarker, +  evidence supporting biomarker, ++ strong evidence supporting biomarker 
